Here are six key notes:
1. The company reported record US GAAP net income of $13.2 million in the fourth quarter of this year, a 15 percent increase in sales to a record $151.2 million. In the fourth quarter of 2014, the company reported US GAAP income of $10.7 million
2. For the full fiscal year ended July 31, 2015, the company reported record US GAAP net income of $47.9 million on a 16 percent increase in sales to a record $565 million, as compared to a net income of $43.2 last year.
3. Under non-GAAP measures, adjusted net income increased 19 percent this quarter to $16.06 million.
4. For the full fiscal year ended July 31, 2015, the company reported a 17 percent increase in adjusted net income to $60.03.
5. According to Andrew Krakauer, CEO of Cantel Medical, “[The] Medivators Endoscopy segment led sales growth for the company this quarter with a robust year-over-year increase of 27 percent, of which 17 percent was organic.”
6. For the full fiscal year 2015, adjusted EBITDAS grew by 17 percent to nearly $114 million, noted Mr. Krakauer.
More articles on GI/endoscopy:
FDA approves new CRC drug
Beyond patient care: The biggest challenges in GI
4 GI physicians in the news – Sept. 25, 2015
